Invibio Company Logo

PEEK-OPTIMA™ Image Contrast (Low radioactivity)

1 of 7 products in this brand
PEEK-OPTIMA™ Image Contrast (Low radioactivity) compounds, from Invibio® Biomaterial Solutions, offer implant manufacturers all the benefits of PEEK-OPTIMA polymer, now with tailored radiopacity. These compounds comprise an image contrast additive at specified levels, providing a broad contrast range for optimal visualization with x-ray, CT and MRI imaging modalities PEEK-OPTIMA image contrast grades are safe, biocompatible materials intended for implantable medical and pharmaceutical devices and applications requiring blood, bone or tissue contact of more than 30 days.

Polymer Name: Polyetheretherketone (PEEK)

Processing Methods: Extrusion, Injection Molding

Flexural Modulus: 3800.0 - 3800.0 MPa

Technical Data Sheet
  • TypeDocument Name
View All Documents

Knowde Enhanced TDS

Identification & Functionality

Technologies

Features & Benefits

Features & Benefits

These compounds provide a unique combination of features and benefits, including:
• Tailored radiopacity allows implant visibility to be optimized
• PEEK-OPTIMA polymer provides a superior combination of strength, stiffness and toughness, even after sterilization
• Biocompatibility ensures safe, long term implantation
• Processing methods allow broad design and manufacturing flexibility
• US FDA Drug and Device Master files can assist with regulatory requirements

Properties

TAILORED IMPLANT RADIOPACITY AND MEDICAL IMAGING COMPATIBILITY

Unlike metals, PEEK-OPTIMA image contrast grades provide the possibility of tailoring the visibility of an implant to suit a particular application. It is therefore possible to achieve an appropriate balance of implant, bone and tissue visualization without arti_x0002_facts or scatter.

DESIGN AND PROCESSING FLEXIBILITY

Available in a range of viscosities (standard, medium and low), PEEK-OPTIMA image contrast grades can be processed by conventional methods, including injection molding and extrusion, and can be machined, allowing medical device manufacturers broad design and manufacturing flexibility.

PROVEN BIOCOMPATIBILITY Extensive testing of PEEK-OPTIMA compounds to ISO 10993 standards demonstrated no evidence of cyto_x0002_toxicity, systemic toxicity or irritation. Results have been lodged with the US FDA and can reduce the time and expense of the approval process.

Applications & Uses

Plastics & Elastomers End Uses
Plastics & Elastomers Processing Methods

Properties

Typical Properties
ValueUnitsTest Method / Conditions
Tensile Strength95MPaISO 527
Tensile Elongation (Break)20%ISO 527
Flexural Modulus3.8GPaISO 178
Flexural Strength150MPaISO 178
Notvhed Izod Impact7kJ/mISO 180
Specific Gravity1.36g/ccISO 1183

Regulatory & Compliance

Certifications & Compliance
Quality & Integrity Assured

In compliance with ISO 13485:2003 and ISO 9001:2000 standards, Invibio embraces all the principles of Good Manufacturing Practice (GMP) in relation to the manufacture of PEEK-OPTIMA image contrast compounds

Technical Details & Test Data

CT Imaging Comparison of Spinal Implants in a Phantom

PEEK-OPTIMA™ Image Contrast (Low radioactivity) - Ct Imaging Comparison of Spinal Implants in A Phantom

X-ray Imaging Comparison of Spinal Implants in a Phantom

PEEK-OPTIMA™ Image Contrast (Low radioactivity) - X-Ray Imaging Comparison of Spinal Implants in A Phantom